Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

This study has been terminated.

( slow accrual for Cohort II )

Study NCT00005997 Information provided by Case Comprehensive Cancer Center

First Received: July 5, 2000 Last Updated: June 9, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	November 2005
Primary Completion Date:	April 2005 (Final data collection date for primary outcome measure)

Publications:

Dowlati A, Posey J, Ramanathan RK, Rath L, Fu P, Chak A, Krishnamurthi S, Brell J, Ingalls S, Hoppel CL, Ivy P, Remick SC. Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers. Cancer Chemother Pharmacol. 2009 Dec;65(1):73-8. Epub 2009 Apr 28.

Dowlati A, Posey J, Ramanathan RK, et al.: Multicenter phase II and pharmacokinetic study of rebeccamycin analogue (RA) in advanced biliary cancers. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-1070, 2003.